HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VIGONVITA-B

87.150

+0.7000.81%

Volume:90.80K

Turnover:8.16M

Market Cap:14.64B

PE:-32.05

High:93.400

Open:89.800

Low:85.000

Close:86.450

52wk High:134.900

52wk Low:51.000

Shares:168.00M

HK Float Shares:167.00M

Volume Ratio:1.00

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.719

ROE:-123.98%

ROA:-20.73%

PB:28.12

PE(LYR):-32.05

PS:122.90

Loading ...

Overview Company News Filings

VIGONVITA-B Reports FY2025 Results: Shareholder Loss Widens to 356 Million Yuan

BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 Million

Vigonvita Life Sciences 2025: Revenue Jumps 7.63-fold but Loss Widens on Share-Based Payments and IPO Costs

Bulletin Express

Vigonvita Life Sciences Co Ltd - FY Total Loss Attributable RMB355.7 Mln

THOMSON REUTERS

Vigonvita Life Sciences Proposes Articles Amendment After H-Share Listing; Registered Capital to Rise to RMB167.60 Million

Bulletin Express

VIGONVITA-B (02630) EGM Green-lights H Share Award Scheme with 100% Support

Bulletin Express

Vigonvita Life Sciences Co. Ltd. held an extraordinary general meeting with 72.79% shareholder attendance

VIGONVITA-B (02630) Sets 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

VIGONVITA-B (02630) Announces Monthly Capital Structure Update

Bulletin Express

Vigonvita Life Sciences (2630) Announces EGM on March 19, 2026 to Consider H Share Award Scheme

Bulletin Express

Vigonvita Life Sciences (2630) Announces EGM and Proposes H Share Award Scheme

Bulletin Express

Vigonvita Life Sciences Co. Ltd. Announces Extraordinary General Meeting

Vigonvita Life Sciences (2630) Proposes Trustee Change for H Share Award Scheme

Bulletin Express

VIGONVITA-B (02630) Announces Change in Trustee for H-Share Reward Scheme

Vigonvita Life Sciences (2630) Announces Book Closure Period for EGM

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/02630/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","market":"HK","secType":"STK","nameCN":"VIGONVITA-B","latestPrice":87.15,"timestamp":1787299687040,"preClose":86.45,"halted":0,"volume":90800,"delay":0,"changeRate":0.008097165991902867,"floatShares":167000000,"shares":168000000,"eps":-2.718847948309796,"marketStatus":"Market Closed","change":0.7,"latestTime":"08-21 16:08:07","open":89.8,"high":93.4,"low":85,"amount":8159170,"amplitude":0.097166,"askPrice":87.15,"askSize":200,"bidPrice":86.55,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-2.7421856989390645,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1762358400000,"exchange":"SEHK","adjPreClose":86.45,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.9951775554496757,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","floatShares":167000000,"roa":"-20.73%","roe":"-123.98%","lyrEps":-2.718848,"volumeRatio":0.9951775554496757,"shares":168000000,"dividePrice":0,"high":93.4,"amplitude":0.097166,"preClose":86.45,"low":85,"week52Low":51,"pbRate":"28.12","psRate":"122.90","week52High":134.9,"institutionHeld":0,"latestPrice":87.15,"committee":0.5,"eps":-2.718847948309796,"divideRate":0,"volume":90800,"delay":0,"ttmEps":-2.7421856989390645,"open":89.8,"prevYearClose":81.85,"prevWeekClose":91.9,"prevMonthClose":95.15,"prevQuarterClose":63.55,"fiveDayClose":91.9,"twentyDayClose":78,"sixtyDayClose":82.7,"earningDate":1787846400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02630\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-31","symbol":"02630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02630\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02630","date":"2026-08-21","current":-31.781217,"percent":0.098446,"low":-51.703739,"twenty":-30.680976,"median":-23.843893,"eighty":-16.143388,"high":-9.647367,"avg":-24.490606,"sd":8.071886,"marketCap":14606148270},"quantilePoints":[{"date":"2025-11-07","current":-19.090342,"twenty":-21.84559,"median":-19.090342,"eighty":-13.424557,"marketCap":4407358491},{"date":"2025-11-14","current":-19.641187,"twenty":-19.420849,"median":-16.095168,"eighty":-15.264414,"marketCap":4547380470},{"date":"2025-11-21","current":-17.28769,"twenty":-19.452561,"median":-18.09445,"eighty":-15.501254,"marketCap":4000627980},{"date":"2025-11-28","current":-20.095977,"twenty":-19.591091,"median":-19.037434,"eighty":-16.046947,"marketCap":4667399310},{"date":"2025-12-05","current":-22.096294,"twenty":-21.259546,"median":-19.451229,"eighty":-16.716837,"marketCap":5140806954},{"date":"2025-12-12","current":-20.997063,"twenty":-21.601599,"median":-19.578567,"eighty":-17.610394,"marketCap":4894101562},{"date":"2025-12-19","current":-23.416326,"twenty":-21.853997,"median":-20.095977,"eighty":-18.35497,"marketCap":5470858762},{"date":"2025-12-24","current":-23.9553,"twenty":-22.587001,"median":-20.380599,"eighty":-18.745749,"marketCap":5614214598},{"date":"2026-01-02","current":-23.818881,"twenty":-23.195416,"median":-20.975608,"eighty":-18.936771,"marketCap":5604213028},{"date":"2026-01-09","current":-24.028271,"twenty":-23.242124,"median":-21.499422,"eighty":-19.069179,"marketCap":5667556305},{"date":"2026-01-16","current":-25.359291,"twenty":-23.625318,"median":-21.781264,"eighty":-19.370201,"marketCap":6000941970},{"date":"2026-01-23","current":-26.793845,"twenty":-23.828886,"median":-22.096294,"eighty":-19.449016,"marketCap":6334327635},{"date":"2026-01-30","current":-27.921283,"twenty":-24.928673,"median":-22.61666,"eighty":-19.453005,"marketCap":6631040876},{"date":"2026-02-06","current":-29.544924,"twenty":-25.987891,"median":-22.879289,"eighty":-19.503447,"marketCap":7034437531},{"date":"2026-02-13","current":-30.629205,"twenty":-27.286118,"median":-23.1966,"eighty":-19.616139,"marketCap":7334484630},{"date":"2026-02-20","current":-34.884005,"twenty":-27.587073,"median":-23.306067,"eighty":-19.674728,"marketCap":8341309338},{"date":"2026-02-27","current":-31.168111,"twenty":-28.783656,"median":-23.424434,"eighty":-19.866309,"marketCap":7534516029},{"date":"2026-03-06","current":-27.5285,"twenty":-28.691787,"median":-23.667752,"eighty":-20.125096,"marketCap":6601036167},{"date":"2026-03-13","current":-30.889856,"twenty":-29.277344,"median":-23.818881,"eighty":-20.297184,"marketCap":7441168042},{"date":"2026-03-20","current":-35.008205,"twenty":-30.149829,"median":-23.991785,"eighty":-20.606532,"marketCap":8401318758},{"date":"2026-03-27","current":-24.261842,"twenty":-30.04822,"median":-24.440897,"eighty":-20.962736,"marketCap":5807578284},{"date":"2026-04-02","current":-13.839173,"twenty":-29.95186,"median":-24.028271,"eighty":-20.954154,"marketCap":5600879172},{"date":"2026-04-10","current":-14.403566,"twenty":-29.707698,"median":-23.912102,"eighty":-20.183335,"marketCap":5874255417},{"date":"2026-04-17","current":-13.931767,"twenty":-29.472848,"median":-23.687448,"eighty":-19.490947,"marketCap":5684225588},{"date":"2026-04-24","current":-13.154764,"twenty":-29.345649,"median":-23.63573,"eighty":-19.048016,"marketCap":5367509206},{"date":"2026-04-30","current":-11.730061,"twenty":-29.261806,"median":-23.42038,"eighty":-17.610394,"marketCap":4787418149},{"date":"2026-05-08","current":-12.584922,"twenty":-29.118763,"median":-23.285925,"eighty":-15.264414,"marketCap":5154142380},{"date":"2026-05-15","current":-12.982213,"twenty":-28.928188,"median":-23.15168,"eighty":-14.197911,"marketCap":5330836783},{"date":"2026-05-22","current":-13.28049,"twenty":-28.680958,"median":-22.671486,"eighty":-13.975486,"marketCap":5440854052},{"date":"2026-05-29","current":-30.758632,"twenty":-28.951155,"median":-22.671486,"eighty":-13.922465,"marketCap":12645254010},{"date":"2026-06-05","current":-26.663627,"twenty":-28.786309,"median":-23.15168,"eighty":-13.953626,"marketCap":10977655900},{"date":"2026-06-12","current":-24.767111,"twenty":-28.478214,"median":-23.285925,"eighty":-14.04116,"marketCap":10189946240},{"date":"2026-06-18","current":-23.79348,"twenty":-28.413466,"median":-23.416326,"eighty":-14.041546,"marketCap":9812851190},{"date":"2026-06-26","current":-24.094013,"twenty":-28.02179,"median":-23.475951,"eighty":-14.17377,"marketCap":9888270200},{"date":"2026-07-03","current":-23.973985,"twenty":-27.941384,"median":-23.572922,"eighty":-14.1825,"marketCap":9846370750},{"date":"2026-07-10","current":-22.062739,"twenty":-27.729315,"median":-23.424434,"eighty":-14.21114,"marketCap":9050281200},{"date":"2026-07-17","current":-23.043014,"twenty":-27.655709,"median":-23.42038,"eighty":-14.359864,"marketCap":9486035480},{"date":"2026-07-24","current":-31.748257,"twenty":-27.941384,"median":-23.52511,"eighty":-14.401931,"marketCap":13072628400},{"date":"2026-07-31","current":-38.65537,"twenty":-28.640355,"median":-23.612983,"eighty":-14.919422,"marketCap":15946930670},{"date":"2026-08-07","current":-47.358881,"twenty":-29.345649,"median":-23.667752,"eighty":-15.264958,"marketCap":19575423040},{"date":"2026-08-14","current":-37.215568,"twenty":-30.11107,"median":-23.79348,"eighty":-15.618859,"marketCap":15402237820},{"date":"2026-08-21","current":-35.214198,"twenty":-30.680976,"median":-23.843893,"eighty":-16.143388,"marketCap":14606148270}],"updateTime":1787454447059},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02630\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166352107","title":"VIGONVITA-B Reports FY2025 Results: Shareholder Loss Widens to 356 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1166352107","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166352107?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:58","pubTimestamp":1774972704,"startTime":"0","endTime":"0","summary":"VIGONVITA-B (02630) announced its annual results for the period ended December 31, 2025. The company recorded revenue of 102 million yuan, representing a significant increase of 762.9% compared to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623533184","title":"BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623533184","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623533184?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:23","pubTimestamp":1774970639,"startTime":"0","endTime":"0","summary":"BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 MillionMarch 31 (Reuters) - Vigonvita Life Sciences Co Ltd 2630.HK:FY TOTAL LOSS ATTRIBUTABLE RMB355.7 MILLIONFY REVENUE RMB102.1 MILLIONFurther company coverage: 2630.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159080130","title":"Vigonvita Life Sciences 2025: Revenue Jumps 7.63-fold but Loss Widens on Share-Based Payments and IPO Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=1159080130","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159080130?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:07","pubTimestamp":1774969638,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. reported audited results for the year ended 31 December 2025. Financial Snapshot   • Revenue surged to RMB 102.10 million, up 762.9% year-on-year, driven by the July...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623453814","title":"Vigonvita Life Sciences Co Ltd -  FY Total Loss Attributable RMB355.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623453814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623453814?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:52","pubTimestamp":1774968761,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130638221","title":"Vigonvita Life Sciences Proposes Articles Amendment After H-Share Listing; Registered Capital to Rise to RMB167.60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1130638221","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130638221?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:27","pubTimestamp":1774967232,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) has released an announcement detailing plans to amend multiple clauses in its Articles of Association following the company’s H-share listing on 6...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158487800","title":"VIGONVITA-B (02630) EGM Green-lights H Share Award Scheme with 100% Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1158487800","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158487800?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:00","pubTimestamp":1773928859,"startTime":"0","endTime":"0","summary":"On 19 March 2026, Vigonvita-B (02630) announced the poll results of its Extraordinary General Meeting held the same day in Suzhou. The sole agenda item—adoption of an H Share Award Scheme and related...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620265022","title":"Vigonvita Life Sciences Co. Ltd. held an extraordinary general meeting with 72.79% shareholder attendance","url":"https://stock-news.laohu8.com/highlight/detail?id=2620265022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620265022?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:45","pubTimestamp":1773927940,"startTime":"0","endTime":"0","summary":"Shareholders approved the adoption of the H Share Award Scheme.The meeting also approved authorizing the board to handle matters related to the H Share Award Scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDLw5zX5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130554739","title":"VIGONVITA-B (02630) Sets 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1130554739","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130554739?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:23","pubTimestamp":1773872594,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B, 02630) has announced that its board of directors will convene on 31 March 2026. The agenda includes: • Reviewing and approving the Group’s audited...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188637829","title":"VIGONVITA-B (02630) Announces Monthly Capital Structure Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1188637829","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188637829?lang=en_us&edition=fundamental","pubTime":"2026-03-05 06:25","pubTimestamp":1772663113,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (stock code: 02630) has issued a monthly update for the period ended 28 February 2026. According to the announcement dated 5 March 2026, the total authorized share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159419752","title":"Vigonvita Life Sciences (2630) Announces EGM on March 19, 2026 to Consider H Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159419752","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159419752?lang=en_us&edition=fundamental","pubTime":"2026-03-02 23:02","pubTimestamp":1772463726,"startTime":"0","endTime":"0","summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of the notice from Vigonvita Life Sciences Co., Ltd. (the “Company”), make...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120033213","title":"Vigonvita Life Sciences (2630) Announces EGM and Proposes H Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1120033213","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120033213?lang=en_us&edition=fundamental","pubTime":"2026-03-02 23:01","pubTimestamp":1772463712,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (Stock code: 2630) has scheduled an Extraordinary General Meeting (EGM) for Thursday, March 19, 2026, at 10:00 a.m. The venue for the EGM is on the 8th Floor,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616135594","title":"Vigonvita Life Sciences Co. Ltd. Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2616135594","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616135594?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:46","pubTimestamp":1772462819,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co. Ltd. will hold an extraordinary general meeting on March 19, 2026 in Suzhou, PRC. Shareholders will vote on a special resolution to approve the adoption of the H Share Award Scheme and to authorize the board to handle matters relating to the H Share Award Scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLbFNLv5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115398179","title":"Vigonvita Life Sciences (2630) Proposes Trustee Change for H Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1115398179","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115398179?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:01","pubTimestamp":1772456483,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (the “Company”) (Stock Code: 2630) issued an announcement regarding a proposed change of trustee for its H Share Award Scheme. According to the Company, JLT Trust...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171610101","title":"VIGONVITA-B (02630) Announces Change in Trustee for H-Share Reward Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1171610101","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171610101?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:52","pubTimestamp":1772455938,"startTime":"0","endTime":"0","summary":"VIGONVITA-B (02630) has announced that on March 2, 2026, in order to optimize the management efficiency and operational arrangements of its share reward scheme, the company proposed a change of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168223681","title":"Vigonvita Life Sciences (2630) Announces Book Closure Period for EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1168223681","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168223681?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:41","pubTimestamp":1772455279,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (2630) will hold an extraordinary general meeting on March 19, 2026, at 10:00 a.m. in Suzhou, China. The register of members of H Shares will be closed from March...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":55,"code":"91000000","status":"200"}]}}